It supports your metabolism from within helping you feel full naturally, manage cravings, and maintain energy
Heres my small take on the GLP 1 revolution
TripleHormone-Receptor Agonist Retatrutide for Obesity . The New England Journal of Medicine
#Diabetes #Obesity #GLP1 #HealthcareInnovation #Pharmaceuticals #CardiometabolicHealth To view or add a comment, sign in More Relevant Posts Eli Lilly and Company reported results from ACHIEVE-3, the first head-to-head #Phase3 trial evaluating the safety and efficacy of orforglipron, a small molecule oral GLP-1 without food or water restrictions, compared with oral semaglutide in adults with #Type2Diabetes
However, the EMA advises against using liraglutide and semaglutide in individuals with a creatinine clearance below 30 mL/min, which corresponds to CKD stages 4 and 5 or kidney failure
Did the authors limit the types of persons with Parkinsons disease who were allowed to enroll in the trial